Amplification pattern of 12q13–q15 genes (MDM2, CDK4, GLI) in urinary bladder cancer

TNM Classification of Malignant Tumours

Hermanek, P., & Sobin, L. H. (1987) · Springer eBooks · doi:10.1007/978-3-642-82982-6 · Cited by 16,073 · see citing works

Tissue microarrays for high-throughput molecular profiling of tumor specimens

Kononen, J., Bubendorf, L., Kallionimeni, A., Barlund, M. T., Schraml, P., Leighton, S. B., Torhorst, J. K. H., Mihatsch, M. J., Sauter, G., & Kallionimeni, O.-P. (1998) · Nature Medicine · doi:10.1038/nm0798-844 · Cited by 4,101 · see citing works

The MDM2 gene amplification database

Momand, J. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.15.3453 · Cited by 982 · see citing works

Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas.

Khatib, Z. A., Matsushime, H., Valentine, M. B., Shapiro, D. N., Sherr, C. J., & Look, A. T. (1993) · PubMed · Cited by 339 · see citing works

Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization

Marchio, A., Meddeb, M., Pineau, P., Danglot, G., Tiollais, P., Bernheim, A., & Dejean, A. (1997) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199701)18:1 · Cited by 266 · see citing works

Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization.

Richter, J., Jiang, F., Görög, J. P., et al. (1997) · PubMed · Cited by 254 · see citing works

High-Throughput Tissue Microarray Analysis of Cyclin E Gene Amplification and Overexpression in Urinary Bladder Cancer

Richter, J., Wagner, U., Kononen, J., Fijan, A., Bruderer, J., Schmid, U., Ackermann, D., Maurer, R. E., Alund, G., Knönagel, H., et al. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64592-0 · Cited by 242 · see citing works

Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization

Kallioniemi, A. H., Kallioniemi, O., Citro, G., Sauter, G., DeVries, S., KERSCHMANN, R. L., Caroll, P. R., & Waldman, F. (1995) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870120309 · Cited by 230 · see citing works

Altered Patterns of MDM2 and TP53 Expression in Human Bladder Cancer

LIANES, P., Orlow, I., Zhang, Z., Oliva, M. R., Sarkis, A. S., Reuter, V. E., & Cordon‐Cardo, C. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.17.1325 · Cited by 194 · see citing works

Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases

Bruns, C. J., Liu, W., Davis, D. W., Shaheen, R. M., McConkey, D. J., Wilson, M. R., Bucana, C. D., Hicklin, D. J., & Ellis, L. M. (2000) · Cancer · doi:10.1002/1097-0142(20000801)89:3 · Cited by 187 · see citing works

Complex composition and co‐amplification of SAS and MDM2 in ring and giant rod marker chromosomes in well‐differentiated liposarcoma

Pédeutour, F., Suijkerbuijk, R. F., Forus, A., Gaal, J., Klundert, W. V. D., Coindre, J., Nicolò, G., Collin, F., Haelst, U., Huffermann, K., et al. (1994) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870100203 · Cited by 182 · see citing works

Regulation of androgen-dependent prostatic cancer cell growth: androgen regulation of CDK2, CDK4, and CKI p16 genes.

Lu, S., Tsai, S. Y., & Tsai, M. (1997) · PubMed · Cited by 176 · see citing works

Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets.

Reifenberger, G., Ichimura, K., REIFENBERGER, J., ELKAHLOUN, A. G., Meltzer, P. S., & Collins, V. P. (1996) · PubMed · Cited by 175 · see citing works

Gene Amplification and Overexpression of CDK4 in Sporadic Breast Carcinomas Is Associated with High Tumor Cell Proliferation

An, H., Beckmann, M. W., Reifenberger, G., Bender, H., & Niederacher, D. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65257-1 · Cited by 160 · see citing works

p53 and vascular-endothelial-growth-factor (VEGF) expression predicts outcome in 833 patients with primary breast carcinoma

Linderholm, B. K., Lindh, B., Tavelin, B., Grankvist, K., & Henriksson, R. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000120)89:1 · Cited by 156 · see citing works

Patterns of Chromosomal Imbalances in Advanced Urinary Bladder Cancer Detected by Comparative Genomic Hybridization

Richter, J., Beffa, L., Wagner, U., Schraml, P., Gasser, T. C., Moch, H., Mihatsch, M. J., & Sauter, G. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65750-1 · Cited by 150 · see citing works

CDK4 gene amplification in osteosarcoma: Reciprocal relationship withINK4A gene alterations and mapping of 12q13 amplicons

Guo, W., Lonardo, F., Ueda, T., Kim, T. K., Huvos, A. G., Healey, J. H., & Ladanyi, M. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990118)80:2 · Cited by 120 · see citing works

The Role of p53, MDM2 and c-erb B-2 Oncoproteins, Epidermal Growth Factor Receptor and Proliferation Markers in the Prognosis of Urinary Bladder Cancer

Korkolopoulou, P. A., Christodoulou, P. N., Kapralos, P., Exarchakos, M., Bisbiroula, A., Hadjiyannakis, M., Georgountzos, C., & Thomas-Tsagli, E. (1997) · Pathology - Research and Practice · doi:10.1016/s0344-0338(97)80055-6 · Cited by 100 · see citing works

Oncogene Amplification in Urothelial Cancers With p53 Gene Mutation or MDM2 Amplification

Habuchi, T., Kinoshita, H., Yamada, H., Kakehi, Y., Ogawa, O., Wu, W., Takahashi, R., Sugiyama, T., & Yoshida, O. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.17.1331 · Cited by 96 · see citing works

Relation between aberrant α-catenin expression and loss of E-cadherin function in prostate cancer

Umbas, R., Isaacs, W. B., Bringuier, P. P., Xue, Y., Debruyne, F. M. J., & Schalken, J. A. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970822)74:4 · Cited by 92 · see citing works

The expression of MDM2/CDK4 gene product in the differential diagnosis of well differentiated liposarcoma and large deep-seated lipoma

Pilotti, S., Torre, G. D., Mezzelani, A., et al. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1090 · Cited by 87 · see citing works

The tumorigenic potential and cell growth characteristics of p53-deficient cells are equivalent in the presence or absence of Mdm2

Jones, S. N., Sands, A., Hancock, A. R., Vogel, H. S., Donehower, L. A., Linke, S. P., Wahl, G. M., & Bradley, A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14106 · Cited by 87 · see citing works

Twelve amplified and expressed genes localized in a single domain in glioma

Fischer, U., Meltzer, P. S., & Meese, E. U. (1996) · Human Genetics · doi:10.1007/s004390050271 · Cited by 81 · see citing works

Fractal characterization of chromatin appearance for diagnosis in breast cytology

Einstein, A. J., Wu, H., Sánchez, M. A., & Gil, J. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199808)185:4 · Cited by 81 · see citing works

Gene amplification as a prognostic factor in primary and secondary high-grade malignant gliomas.

Galanis, E., Buckner, J. C., Kimmel, D. W., et al. (1998) · International Journal of Oncology · doi:10.3892/ijo.13.4.717 · Cited by 78 · see citing works

Amplification of the cyclin-dependent kinase 4 ( CDK4 ) gene is associated with high cdk4 protein levels in glioblastoma multiforme

Rollbrocker, B., Waha, A., Louis, D. N., Wiestler, O. D., & von Deimling, A. (1996) · Acta Neuropathologica · doi:10.1007/s004010050491 · Cited by 70 · see citing works

Characteristics of genomic breakpoints in TLS-CHOP translocations in liposarcomas suggest the involvement of Translin and topoisomerase II in the process of translocation

Kanoe, H., Nakayama, T., Hosaka, T., Murakami, H., Yamamoto, H., Nakashima, Y., Tsuboyama, T., Nakamura, T., Ron, D., Sasaki, M. S., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202364 · Cited by 68 · see citing works

Detection of Genetic Alterations in Bladder Tumors by Comparative Genomic Hybridization and Cytogenetic Analysis

Koo, S. H., Kwon, K. C., Ihm, C. H., Jeon, Y. M., Park, J. W., & Sul, C.-K. (1999) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(98)00193-9 · Cited by 67 · see citing works

p53 and MDM2 in the Development and Progression of Bladder Cancer

Ackermann, R., Schmitz-Dräger, B. J., Kushima, M., Goebell, P., Jax, T. W., Gerharz, C.-D., Bültel, H., Schulz, W. A., & Ebert, T. (1997) · European Urology · doi:10.1159/000480813 · Cited by 66 · see citing works

Clinical Significance of mdm2 and p53 Expression in Bladder Cancer

Shiina, H., Igawa, M., Shigeno, K., Yamasaki, Y., Urakami, S., Yoneda, T., Wada, Y., Honda, S., & Nagasaki, M. (1999) · Oncology · doi:10.1159/000011971 · Cited by 64 · see citing works

Patterns of chromosomal imbalances in muscle invasive bladder cancer.

Simon, R., Bürger, H., Semjonow, A., et al. (2000) · International Journal of Oncology · doi:10.3892/ijo.17.5.1025 · Cited by 63 · see citing works

Analysis of 12q13-15 Genes in Parosteal Osteosarcoma

Gamberi, G., Ragazzini, P., Benassi, M. S., Ferrari, C., Sollazzo, M. R., Molendini, L., Merli, M., Magagnoli, G., Ruggieri, P., Balladelli, A., et al. (2000) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-200008000-00026 · Cited by 52 · see citing works

Cyclin D1 overexpression in invasive breast cancers: correlation with cyclin-dependent kinase 4 and oestrogen receptor overexpression, and lack of correlation with mitotic activity

Takano, Y., Takenaka, H., Kato, Y., Masuda, M., Mikami, T., Saegusa, M., & Okayasu, I. (1999) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s004320050309 · Cited by 45 · see citing works

Loss of heterozygosity analysis of 13q and 14q in human malignant mesothelioma

Rienzo, A. D., Jhanwar, S. C., & Testa, J. R. (2000) · Genes Chromosomes and Cancer · doi:10.1002/1098-2264(200007)28:3 · Cited by 30 · see citing works

Immunohistochemical expression of retinoblastoma gene product (Rb), p53 protein, MDM2, c-erbB-2, HLA-DR and proliferation indices in human urinary bladder carcinoma.

Ioachim, E. E., Charchanti, A. V., Stavropoulos, N. E., Skopelitou, A. S., Athanassiou, E. D., & Agnantis, N. J. (2000) · PubMed · doi:10.14670/hh-15.721 · Cited by 26 · see citing works

Expression of G1→S Transition Regulatory Molecules in Human Urothelial Cancer

Oya, M., Schmidt, B., Schmitz‐Dräger, B. J., et al. (1998) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1998.tb03276.x · Cited by 24 · see citing works

Untitled work

Berner (1996) · doi:10.1002/(sici)1098-2264(199612)17:4

Regulating the p53 pathway: in vitro hypotheses, in vivo veritas

Toledo, F., & Wahl, G. M. (2006) · Nature reviews. Cancer · doi:10.1038/nrc2012 · Cited by 1,286 · see citing works

MDM2 and Human Malignancies: Expression, Clinical Pathology, Prognostic Markers, and Implications for Chemotherapy

Rayburn, E., Zhang, R., He, J., & Wang, H. (2005) · Current Cancer Drug Targets · doi:10.2174/1568009053332636 · Cited by 265 · see citing works

Amplification of <i>CDK4</i> and <i>MDM2</i> in malignant melanoma

Muthusamy, V., Hobbs, C., Nogueira, C., Cordon‐Cardo, C., McKee, P. H., Chin, L., & Bosenberg, M. W. (2006) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20310 · Cited by 148 · see citing works

Characterization of the 12q15 <i>MDM2</i> and 12q13‐14 <i>CDK4</i> amplicons and clinical correlations in osteosarcoma

Mejia‐Guerrero, S., Quejada, M., Gokgoz, N., Gill, M., Parkes, R. K., Wunder, J. S., & Andrulis, I. L. (2010) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20761 · Cited by 120 · see citing works

Rational drug design, synthesis, and biological evaluation of novel chiral tetrahydronaphthalene-fused spirooxindole as MDM2-CDK4 dual inhibitor against glioblastoma

Wang, B., Peng, F., Huang, W., Zhou, J., Zhang, N., Sheng, J., Haruehanroengra, P., He, G., & Han, B. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.12.013 · Cited by 73 · see citing works

Clinical findings in individuals with duplication of genes associated with X‐linked intellectual disability

Sahajpal, N., Ziats, C. A., Chaubey, A., DuPont, B. R., Abidi, F., Schwartz, C. E., & Stevenson, R. E. (2023) · Clinical Genetics · doi:10.1111/cge.14445 · Cited by 4 · see citing works

Duplication processes in Saccharomyces cerevisiae haploid strains

Schacherer, J. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki941 · Cited by 25 · see citing works

SELECTION FOR A LARGE GENETIC DUPLICATION IN SALMONELLA TYPHIMURIUM

Straus, D. S., & Hoffmann, G. R. (1975) · Genetics · doi:10.1093/genetics/80.2.227 · Cited by 43 · see citing works

The preliminary report on the C4 gene duplication in chinese

Xiu-zhu, Z. (1993)

Detection of duplication in Charcot-Marie-Tooth disease type 1A

Yu-wei, D. (2000)